A new Guidelines on Hospital Pharmacy Manpower in Saudi Arabia

2016 ◽  
Vol 2 (2) ◽  
pp. 30-31 ◽  
Author(s):  
Yousef Ahmed Alomi
Keyword(s):  
Saudi Arabia ◽  
Hospital Pharmacy ◽  
New Guidelines

scholarly journals Hospital pharmacy practice in Saudi Arabia: Prescribing and transcribing in the Riyadh region

2012 ◽  
Vol 20 (3) ◽  
pp. 203-210 ◽  
Author(s):  
Mohammed S. Alsultan ◽  
Fowad Khurshid ◽  
Heba J. Salamah ◽  
Ahmed Y. Mayet ◽  
Ahmed H. Al-jedai
Keyword(s):  
Saudi Arabia ◽  
Hospital Pharmacy ◽  
Pharmacy Practice

scholarly journals Hospital Pharmacy Preparedness and Pharmacist Role During Disaster in Saudi Arabia

2021 ◽  
Vol Volume 14 ◽  
pp. 5039-5046
Author(s):  
Ahmed Aljabri ◽  
Hussain Bakhsh ◽  
Abeer Baageel ◽  
Sara Al-Nimari ◽  
Samah Alshehri ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Hospital Pharmacy ◽  
Pharmacist Role

scholarly journals Hospital pharmacy practice in Saudi Arabia: Dispensing and administration in the Riyadh region

2012 ◽  
Vol 20 (4) ◽  
pp. 307-315 ◽  
Author(s):  
Mohammed S. Alsultan ◽  
Fowad Khurshid ◽  
Ahmed Y. Mayet ◽  
Ahmed H. Al-jedai
Keyword(s):  
Saudi Arabia ◽  
Hospital Pharmacy ◽  
Pharmacy Practice

scholarly journals Hospital pharmacy practice in Saudi Arabia: Drug monitoring and patient education in the Riyadh region

2013 ◽  
Vol 21 (4) ◽  
pp. 361-370 ◽  
Author(s):  
Mohammed S. Alsultan ◽  
Ahmed Y. Mayet ◽  
Fowad Khurshid ◽  
Ahmed H. Al-jedai
Keyword(s):  
Saudi Arabia ◽  
Patient Education ◽  
Drug Monitoring ◽  
Hospital Pharmacy ◽  
Pharmacy Practice

scholarly journals Knowledge, attitude and practice of physicians towards oral anti-coagulants in Taif city, Saudi Arabia

2018 ◽  
Vol 5 (5) ◽  
pp. 1086
Author(s):  
Raghad Alnemari ◽  
Ahmed Banheem ◽  
Naeem Mullaniazee ◽  
Saleh Alghamdi ◽  
Abdulmajeed Rajkhan ◽  
...  
Keyword(s):  
Saudi Arabia ◽  
Adverse Events ◽  
Oral Anticoagulants ◽  
Major Life ◽  
Cross Sectional ◽  
Attitude And Practice ◽  
Pharmacodynamic Profile ◽  
New Guidelines ◽  
Knowledge Attitude And Practice

Background: Thromboembolism is a common phenomenon of major significance. Oral anticoagulants have been used for decades, however, they were associated with many complications and different monitoring techniques. Therefore, novel oral anticoagulants (NOACs) with better efficacy, lower adverse events, superior pharmacokinetic and pharmacodynamic profile were developed. Unfortunately, many of the physicians are still hesitant to prescribe these agents.Methods: This was a cross-sectional study conducted in Taif city on 61 physicians from King Abdulaziz Specialist Hospital and King Faisal Hospital in Taif. A questionnaire was given to participants to answer questions related to knowledge, attitude, and practice of prescription of KA and NOACs, indications of prescription, reasons for non-use, follow up methods adopted, follow up frequency, common adverse events encountered, awareness of new guidelines of NOACs, and providing patients with health education about their medications.Results: Only 69% of participants used NOACs on regular basis, whilst 100% used warfarin. Half of those who didn't prescribe NOACs attributed this to the non-availability of an antidote and fear of toxicity. Twenty-five% considered the NOACs new medications with inadequate clinical trials that make them trustable., and 17% did not prescribe them because of their non-availability at the hospital pharmacy. Only 66% used NOACs in treatment of non-valvular atrial fibrillation. Regarding knowledge, 71% of participants were aware of the new guidelines of NOACs, and 69% of institutions provided educational programs about these new agents. Major life-threatening bleeding was reported in 47.3% and 10.8% of patients on warfarin and NOACs, respectively.Conclusions: Physicians at Taif city in Saudi Arabia had a fairly good knowledge of NOACs. They prescribed them frequently and they were aware with the new guidelines and proper follow-up methods. However, more educational activities are recommended to encourage the rest of physician to use these agents and to correct their defective information about safety issues, pharmacokinetic and pharmacodynamic properties of NOACs, and adverse events.

The Revised Basel Statements on the Future of Hospital Pharmacy: What Do They Mean for Saudi Arabia?

2017 ◽  
Vol 26 (3) ◽  
pp. 281-283
Author(s):  
Hanadi Al Sabban ◽  
Ahmed Al-Jedai ◽  
Dalia Bajis ◽  
Jonathan Penm
Keyword(s):  
Saudi Arabia ◽  
Hospital Pharmacy ◽  
The Future

scholarly journals Hospital Pharmacy Technician Workforce over 12 Years (2006-2017) in Saudi Arabia

2019 ◽  
Vol 8 (3) ◽  
pp. 163-170
Author(s):  
Yousef Ahmed Alomi ◽  
Saeed Jamaan Alghamdi ◽  
Radi Abdullah Alattyh
Keyword(s):  
Saudi Arabia ◽  
Hospital Pharmacy ◽  
Pharmacy Technician

scholarly journals The Health Belief Model and Preventive Measures: A Study of the Ministry of Health Campaign on Coronavirus in Saudi Arabia

2018 ◽  
Vol 1 (1) ◽  
pp. 27-56 ◽  
Author(s):  
Saud Alsulaiman ◽  
Terry Rentner
Keyword(s):  
Saudi Arabia ◽  
Preventive Measures ◽  
Health Belief ◽  
Health Campaign ◽  
Ministry Of Health ◽  
King Saud University ◽  
New Guidelines ◽  
Belief Model ◽  
Recommended Guidelines ◽  
The Health Belief Model

As of August 2017, approximately 684 people have died in the Kingdom of Saudi Arabia since the coronavirus Middle East respiratory syndrome (MERS-CoV) outbreak in 2012. Saudi Arabia became the leading country for the number of illnesses and deaths related to MERS-CoV, making this a health megacrisis. Early Ministry of Health (MOH) communication efforts proved ineffective and created anger, confusion, and mistrust. Changes in command, implementation of new guidelines and policies, and a health preventive campaign have been instrumental in the fight. The MOH launched the “We Can Stop It” campaign in 2015. This study shares results from a survey of 875 students from King Saud University on the credibility of MOH information and effectiveness of the campaign’s prevention recommendations. Results show that the MOH is a credible source of information and that Saudis are following most, but not all, recommended preventive measures. Those persons with higher perceived benefits and lower barriers are more likely to follow recommended guidelines.

Sign in / Sign up

Export Citation Format

Share Document